Medical experts have warned native Europeans that they face a “serious” threat of being infected with mass outbreaks of Hepatitis B should they have sexual contact with the current wave of nonwhite invaders.
A paper presented at the annual European Association for the Study of the Liver (EASL) conference in Barcelona, Spain, warned that that the flood of nonwhite invaders pouring into Europe poses “serious challenges” in spreading communicable diseases.
Dr. Philipp Solbach from the Department of Gastroenterology, Hepatology, and Endocrinology of the Medizinsche Hochschule, Hannover, said there are “high levels of hepatitis B markers among overwhelmingly unvaccinated refugee populations in northern Germany.”
Dr. Solbach said that the European Union (EU) “faces serious challenges in responding to the spread of communicable diseases among both refugee and native populations.”
“The prevalence data we have recorded, alongside decreased levels of immunity and non-immunization, reveals the true extent of the public health challenge that Europe is facing with regard to Hepatitis B.”
In the study, the researchers examined 793 invaders of all ages who were living in reception centers in northern Germany in August 2015.
They tested for serological markers (in a component of blood called serum), as well as liver enzymes, that would show Hepatitis B virus infection.
They found that the rates of Hepatitis B infection among the refugees (2.3 percent) was significantly higher than that of the German population (0.7 percent), or Europe in general (2 percent).
The study further revealed that more than half of patients studied (62 percent) had no immunity to Hepatitis B, and only 18.6 percent had been vaccinated against the disease.
Surprised at the results, the researchers then decided to compare the results to the prevalence of the virus in nonwhite “immigrant” populations already living in Germany.
Their findings confirmed their suspicions: around 5 percent of “immigrants” in Germany have Hepatitis B, and large numbers are unvaccinated.
“Syria has a Hepatitis B prevalence of around 2.6 percent, Iraq and Afghanistan a little bit lower, and Albania is quite high, at about 7.7 percent,” Dr Solbach said. “In the European region it’s 2 percent, so there’s a pretty huge difference.”
He continued: “While this study looks at Hepatitis B markers in isolation, there are potential implications for surveillance of communicable diseases across the board.”
Hepatitis B is an infection of the liver caused by a virus that is spread through blood, semen, and other body fluids.
Children—who can be born with the disease from infected mothers—are most at risk, because in infants, Hepatitis B often persists for years and may eventually cause serious liver damage.
The Center for Disease Control (CDC) lists sexual contact as the primary infection route of Hepatitis B, and warns that promiscuous sex is the most common way of spreading the illness.
As a result, it is no surprise to discover that Hepatitis B is particularly common in sub-Saharan Africa, east and southeast Asia, the Pacific Islands, parts of South America, the Middle East, and the Indian subcontinent. According to the World Health Organization, some 240 million people are chronically infected with Hepatitis B.
The implications of this are clear: Europeans who are most at risk are those who engage in sexual contact with the nonwhite invaders, especially the younger males in whom Hepatitis B was found to be most prevalent and who are likely to be the most sexually active.